Pyxis Oncology, Inc. · NASDAQ:PYXS
Ridgeback Capital Investments L.P.'s stake in Pyxis Oncology, Inc. fell to 0.60% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Ridgeback Capital Investments L.P.'s stake in Pyxis Oncology, Inc. fell to 0.60%, 359,231 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 0.60%
- Shares
- 359,231
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ridgeback Capital Investments L.P. | 0.60% | 359,231 |
| Ridgeback Capital Investments LLC | 0.60% | 359,231 |
| Ridgeback Capital Management LLC | 0.60% | 359,231 |
Source
Related
- Pyxis Oncology, Inc.
- Ridgeback Capital Investments L.P.
- Pyxis Oncology, Inc. shareholders
- Schedule 13G/A · GordonMD Global Investments LP · Oct 9, 2026
- Schedule 13G · Coastlands Capital LP · Oct 5, 2026
- Form 4 · GordonMD Global Investments LP · Oct 2, 2026
- Schedule 13G/A · GordonMD Global Investments LP · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Jul 10, 2026